10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
PLEASANTON, Calif., April 10, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report financial results for the first quarter ended March 31, 2024 after market close on Tuesday, April 30, 2024. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible from the company's website prior to the conference call.
加利福尼亞州普萊森頓，2024年4月10日 /PRNewswire/ — 單細胞和空間生物學領域的領導者10x Genomics, Inc.（納斯達克股票代碼：TXG）今天宣佈，將在2024年4月30日星期二收盤後公佈截至2024年3月31日的第一季度財務業績。該公司將從太平洋時間下午 1:30 /美國東部時間下午 4:30 開始爲分析師和投資者舉辦公開電話會議和網絡直播，討論其業績、業務發展和前景。在電話會議之前，將從公司的網站上訪問包含財務業績的新聞稿。
Live audio of the webcast will be available on the "Investors" section of the company website at: . The webcast will be archived and available for replay for at least 45 days after the event.
網絡直播的直播音頻將在公司網站的 “投資者” 部分提供，網址爲： 。網絡直播將在活動結束後至少 45 天內存檔並可供重播。
About 10x Genomics
大約 10 倍基因組學
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).
10x Genomics是一家生命科學技術公司，其產品旨在加速對生物學的掌握並促進人類健康。我們的綜合解決方案包括用於單細胞和空間生物學的儀器、耗材和軟件，可幫助學術和轉化研究人員以及生物製藥公司以與生物學複雜性相匹配的分辨率和規模了解生物系統。我們的產品是腫瘤學、免疫學、神經科學等領域取得突破的推動力，推動了改變世界對健康和疾病的理解的強大發現。要了解更多信息，請訪問 10xgenomics.com 或者通過以下方式聯繫我們 領英 要麼 X (Twitter)。
Disclosure Information
披露信息
10x Genomics uses filings with the Securities and Exchange Commission, our website (), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.
10x Genomics使用向美國證券交易委員會提交的文件、我們的網站 ()、新聞稿、公開電話會議、公開網絡直播和我們的社交媒體賬戶作爲披露重大非公開信息的手段，並用於履行我們在FD法規下的披露義務。
Contacts
Investors: [email protected]
Media: [email protected]
聯繫人
投資者： [電子郵件保護]
媒體： [電子郵件保護]
SOURCE 10x Genomics, Inc
來源 10x Genomics, Inc
譯文內容由第三人軟體翻譯。